These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 14999589)
1. [Intratumoral genomic heterogeneity in head and neck cancer]. Götte K Laryngorhinootologie; 2004 Feb; 83(2):122-3. PubMed ID: 14999589 [No Abstract] [Full Text] [Related]
2. Intratumoral genomic heterogeneity in primary head and neck cancer and corresponding metastases detected by dual-FISH. Götte K; Schäfer C; Riedel F; Arens N; Hörmann K Oncol Rep; 2004 Jan; 11(1):17-23. PubMed ID: 14654897 [TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of gene expression profiles in head and neck cancer. Pramana J; Pimentel N; Hofland I; Wessels LF; van Velthuysen ML; Atsma D; Rasch CR; van den Brekel MW; Begg AC Head Neck; 2007 Dec; 29(12):1083-9. PubMed ID: 17615564 [TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of head and neck tumors by analysis of telomerase activity and a panel of microsatellite markers. Fiedler W; Hoppe C; Schimmel B; Koscielny S; Dahse R; Bereczki Z; Claussen U; Ernst G; von Eggeling F Int J Mol Med; 2002 Apr; 9(4):417-23. PubMed ID: 11891539 [TBL] [Abstract][Full Text] [Related]
5. Head and neck cancer and precancer: can we use molecular genetics to make better predictions? Partridge M Ann R Coll Surg Engl; 1999 Jan; 81(1):1-11. PubMed ID: 10325677 [No Abstract] [Full Text] [Related]
6. Genetic discordance between primary tumours and metastases of head and neck cancer detected by microsatellite analysis. Götte K; Riedel F; Schäfer C; Coy JF; Hörmann K Oncol Rep; 2002; 9(4):829-34. PubMed ID: 12066217 [TBL] [Abstract][Full Text] [Related]
7. Molecular assays for the diagnosis of minimal residual head-and-neck cancer: methods, reliability, pitfalls, and solutions. van Houten VM; Tabor MP; van den Brekel MW; Denkers F; Wishaupt RG; Kummer JA; Snow GB; Brakenhoff RH Clin Cancer Res; 2000 Oct; 6(10):3803-16. PubMed ID: 11051222 [TBL] [Abstract][Full Text] [Related]
8. Unraveling the chromosomal aberrations of head and neck squamous cell carcinoma: a review. Patmore HS; Cawkwell L; Stafford ND; Greenman J Ann Surg Oncol; 2005 Oct; 12(10):831-42. PubMed ID: 16132373 [TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of the proliferative fraction and cyclin D1/CCND1 gene amplification in head and neck squamous cell carcinoma. el-Naggar AK; Steck K; Batsakis JG Cytometry; 1995 Sep; 21(1):47-51. PubMed ID: 8529470 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of microsatellite amplifications at chromosomal locus 3q26 as surrogate marker for premalignant changes in mucosa surrounding head and neck squamous cell carcinoma. Brieger J; Kastner J; Gosepath J; Mann WJ Cancer Genet Cytogenet; 2006 May; 167(1):26-31. PubMed ID: 16682282 [TBL] [Abstract][Full Text] [Related]
11. Genomic instabilities in squamous cell carcinoma of head and neck from the Indian population. Chakrabarti S; Sengupta S; Sengupta A; Basak SN; Roy A; Panda C; Roychoudhury S Mol Carcinog; 2006 Apr; 45(4):270-7. PubMed ID: 16402388 [TBL] [Abstract][Full Text] [Related]
12. Genetic progression model for head and neck cancer: implications for field cancerization. Califano J; van der Riet P; Westra W; Nawroz H; Clayman G; Piantadosi S; Corio R; Lee D; Greenberg B; Koch W; Sidransky D Cancer Res; 1996 Jun; 56(11):2488-92. PubMed ID: 8653682 [TBL] [Abstract][Full Text] [Related]
13. [Influence of genetic variation in the major histocompatibility complex on head and neck cancer susceptibility]. Matthias C; Jahnke V; Hajeer A; Ollier W; Fryer AA; Strange RC Laryngorhinootologie; 2001 Oct; 80(10):595-600. PubMed ID: 11602932 [TBL] [Abstract][Full Text] [Related]
14. Chromosomal alterations during metastasis formation of head and neck squamous cell carcinoma. Bockmühl U; Schlüns K; Schmidt S; Matthias S; Petersen I Genes Chromosomes Cancer; 2002 Jan; 33(1):29-35. PubMed ID: 11746985 [TBL] [Abstract][Full Text] [Related]
15. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors. Cullen KJ; Newkirk KA; Schumaker LM; Aldosari N; Rone JD; Haddad BR Cancer Res; 2003 Dec; 63(23):8097-102. PubMed ID: 14678959 [TBL] [Abstract][Full Text] [Related]
16. Impact of chromosome 14q loss on survival in primary head and neck squamous cell carcinoma. Lee DJ; Koch WM; Yoo G; Lango M; Reed A; Califano J; Brennan JA; Westra WH; Zahurak M; Sidransky D Clin Cancer Res; 1997 Apr; 3(4):501-5. PubMed ID: 9815712 [TBL] [Abstract][Full Text] [Related]
17. An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Ah-See KW; Cooke TG; Pickford IR; Soutar D; Balmain A Cancer Res; 1994 Apr; 54(7):1617-21. PubMed ID: 8137268 [TBL] [Abstract][Full Text] [Related]
18. Multiple head and neck tumors: evidence for a common clonal origin. Bedi GC; Westra WH; Gabrielson E; Koch W; Sidransky D Cancer Res; 1996 Jun; 56(11):2484-7. PubMed ID: 8653681 [TBL] [Abstract][Full Text] [Related]
19. Correspondence re: F. Coulet et al., Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis. Cancer Res., 60: 707-709, 2000. Silva JM; Bonilla F Cancer Res; 2001 Dec; 61(23):8595-6. PubMed ID: 11731447 [No Abstract] [Full Text] [Related]
20. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Tabor MP; Brakenhoff RH; van Houten VM; Kummer JA; Snel MH; Snijders PJ; Snow GB; Leemans CR; Braakhuis BJ Clin Cancer Res; 2001 Jun; 7(6):1523-32. PubMed ID: 11410486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]